AcuityMD
Category: AI in Healthcare
AI platform for MedTech commercial teams, trusted by 500+ medical device companies including 16 of the top 20. AcuityMD was founded in 2019. The company is led by Michael Monovoukas. Based in Boston, MA, USA. Team size: 101-500. Total funding raised: $163 million. Latest round: Series C. Key investors include StepStone Group, Benchmark, Redpoint Ventures, ICONIQ, Atreides Management.
- Founded
- 2019
- Headquarters
- Boston, MA, USA
- Team size
- 101-500
- Total funding
- $163 million
Value proposition
AcuityMD is the MedTech intelligence platform that combines precise data, AI-powered insights, and intuitive workflows to help medical device sales teams identify opportunities and win more deals.
Products and solutions
AcuityMD MedTech Intelligence, AcuityAI
Target customer
MedTech commercial teams (sales, marketing, market access) at medical device companies
Industries served
Medical Technology, Healthcare
Technology advantage
Purpose-built AI platform with proprietary MedTech ontology and HCP procedure data, delivering context-aware insights for the regulated medical device industry.
How they differentiate
AcuityMD uses a purpose-built AI platform with a proprietary MedTech ontology and HCP procedure data, delivering context-aware insights specifically for the regulated medical device industry.
Main competitors
MedScout, Definitive Healthcare, Alpha Sophia, IQVIA
Key partnerships
Snowflake (AcuityMD Encounters Data Mart on Snowflake Marketplace)
Notable customers
16 of the top 20 MedTech companies, 500+ MedTech companies, Olympus, Teleflex, BD (Becton Dickinson), Merit Medical, Route 92 Medical, Intellijoint Surgical, Pristine Surgical, LivsMed
Major milestones
Raised $80M Series C led by StepStone Group at $955M valuation (Apr 2026), Ranked No. 316 on 2026 Inc. 5000 with 1,061% three-year revenue growth (Aug 2026), Launched AcuityMD Encounters Data Mart on Snowflake Marketplace (Jun 2026), Launched AcuityAI in open beta, Trusted by 500+ MedTech companies including 16 of the top 20, Named to Forbes' 2025 'Next Billion-Dollar Startups' list, Raised $45M Series B led by ICONIQ Growth (Jun 2024), Raised $31M Series A led by Redpoint (May 2022)
Growth metrics
2026 Inc. 5000 No. 316 overall; No. 28 of 362 software companies; 1,061% three-year revenue growth; 500+ MedTech customers; ~$34B pipeline identified for customers; ~292 employees
Market positioning
Near-unicorn MedTech commercial intelligence platform ($955M valuation post-Series C); purpose-built AI for medical device sales, marketing, and market access teams.
About Michael Monovoukas
Prior to AcuityMD, Michael was a MedTech entrepreneur and held a leadership role at PatientPing. He also worked at Bain & Company and the Federal Reserve Bank of Boston.
Latest news about AcuityMD
More AI in Healthcare companies
Official website: https://www.acuitymd.com